ONKURE THERAPEUTICS, INC. Total Assets
ONKURE THERAPEUTICS, INC. (OKUR) had Total Assets of $179.35 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-04
- 2026-06-30: Assets $179.35M.
- 2026-03-31: Assets $198.69M.
- 2025-12-31: Assets $62.12M.
- 2025-09-30: Assets $72.83M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $179.35M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $198.69M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $62.12M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $72.83M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $86.07M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $99.88M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $114.91M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $77.64M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $78.72M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $84.64M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $35.73M 10-K · filed 2025-03-10 | $107.44M 10-K · filed 2024-03-28 |
| 2023-09-30 | $130.39M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $148.04M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $98.87M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $108.18M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $122.50M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $133.61M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $144.41M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $154.02M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $162.94M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $171.30M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $95.32M 10-Q · filed 2021-05-20 | |
| 2020-12-31 | $55.22M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |